What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0002030974
Total reported value
$375.8M
$375.8M
295 檔
27.8%
In Q4 2025, Kings Path Partners LLC's U.S. equity holdings reached a combined market value of $375.8M, distributed across 295 disclosed stock positions.
In Q4 2025, Kings Path Partners LLC adopted a defensive or profit-taking posture, trimming 51 positions and completely liquidating 33 holdings to manage risk exposure.
Showing top 200 holdings (of 295 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VTI | Vanguard Total Stock Mkt ETF | ETF-Other | 11.04% | +0.18% | +1.45% | |
| 2 | SCHF | Schwab Intl Equity ETF | ETF-Other | 7.79% | -1.43% | -5.87% | |
| 3 | GSLC | Goldman Activebeta US Lc ETF | ETF-Commodities | 7.56% | -0.30% | +2.03% | |
| 4 | VEA | Vanguard Ftse Developed ETF | ETF-Other | 5.38% | -0.05% | +3.28% | |
| 5 | DFCF | Dimensional Core Fixed Inc | ETF-Other | 4.84% | -0.97% | +6.49% | |
| 6 | VGIT | Vanguard Intermediate-term T | ETF-Other | 4.82% | -0.36% | +8.29% | |
| 7 | VGSH | Vanguard Short-term Treasury | ETF-Gov Bonds | 4.54% | -0.26% | +8.46% | |
| 8 | VWO | Vanguard Ftse Emerging Marke | ETF-Emerging Markets | 4.30% | -0.21% | +1.65% | |
| 9 | AVLV | Avantis US Large Cap Value | ETF-Large Cap & Growth | 3.75% | +0.22% | +4.89% | |
| 10 | GSIE | Goldman Sachs Activebeta Int | ETF-Commodities | 3.61% | -0.19% | -1.02% | |
| 11 | DFAT | Dimensional US Target Value | ETF-Other | 3.53% | +0.26% | +2.35% | |
| 12 | DFIV | Dimensional International Va | ETF-Other | 3.06% | -0.34% | +4.15% | |
| 13 | DFGP | Dimensional Glbl Core Pl Fix | ETF-Other | 2.63% | -0.42% | +24.06% | |
| 14 | VCRB | Vanguard Core Bond ETF | ETF-Other | 2.26% | -0.31% | +19.09% | |
| 15 | AVEM | Avantis Emerging Markets Eq | ETF-Emerging Markets | 2.02% | +0.24% | +4.48% | |
| 16 | AVDV | Avantis Intl S/c Value ETF | ETF-Other | 2.02% | -0.14% | +9.76% | |
| 17 | SCHP | Schwab U.s. Tips ETF | ETF-Other | 1.67% | -0.41% | +1.68% | |
| 18 | ITOT | Ishares Core S&p Total U.s. | ETF-Other | 1.26% | -0.38% | -0.19% | |
| 19 | IEFA | Ishares Core Msci Eafe ETF | ETF-Other | 1.01% | -0.21% | -0.76% | |
| 20 | FNDX | Schwab Fndmntl US Lrg Co ETF | ETF-Other | 0.96% | -0.13% | +18.35% | |
| 21 | BOXX | Alpha Architect 1-3 Mnth Box | ETF-Other | 0.80% | +0.94% | +2909.71% | |
| 22 | BRK-A | Berkshire Hathaway Inc-cl A | Stock-Other | 0.79% | -0.19% | — | |
| 23 | MUB | Ishares National Muni Bond E | ETF-Other | 0.78% | +1.02% | +5.87% | |
| 24 | VGLT | Vanguard Long-term Treasury | ETF-Gov Bonds | 0.75% | -0.14% | +4.62% | |
| 25 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 0.65% | -0.12% | -0.48% | |
| 26 | SHV | Ishares 0-1 Year Treasury Bo | ETF-Gov Bonds | 0.64% | -0.20% | +28.69% | |
| 27 | TRGP | Targa Resources CORP | Stock-Energy | 0.62% | +0.27% | — | |
| 28 | VTEB | Vanguard Tax-exempt Bond ETF | ETF-Other | 0.61% | +1.05% | +8.41% | |
| 29 | SUB | Ishares Short-term National | ETF-Other | 0.53% | +1.15% | +6.41% | |
| 30 | DUSB | Dimension Ultrashort Fi ETF | ETF-Other | 0.50% | +0.28% | -11.34% | |
| 31 | BNDX | Vanguard Total Intl Bond ETF | ETF-Other | 0.43% | -0.14% | -13.81% | |
| 32 | BND | Vanguard Total Bond Market | ETF-Other | 0.40% | -0.11% | -14.99% | |
| 33 | VTIP | Vanguard Short-term Tips | ETF-Other | 0.39% | -0.10% | +9.11% | |
| 34 | XOM | Exxon Mobil CORP | Stock-Energy | 0.35% | -0.05% | — | |
| 35 | MUNI | Pimco Intermediate Municipal | ETF-Other | 0.32% | -0.08% | -1.20% | |
| 36 | FNDF | Schwab Fndmn Intl Lrg Co ETF | ETF-Other | 0.28% | -0.04% | — | |
| 37 | VONV | Vanguard Russell 1000 Value | ETF-Other | 0.27% | -0.03% | — | |
| 38 | DFNM | Dimensional National Muni Bd | ETF-Other | 0.27% | +1.25% | +23.75% | |
| 39 | IEMG | Ishares Core Msci Emerging | ETF-Emerging Markets | 0.26% | -0.03% | -35.67% | |
| 40 | AVUV | Avantis US Small Cap Value | ETF-Small Cap | 0.26% | — | -4.28% | |
| 41 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 0.26% | +0.07% | — | |
| 42 | ACWI | Ishares Msci Acwi ETF | ETF-Other | 0.25% | -0.04% | — | |
| 43 | PDFS | Pdf Solutions Inc | Stock-Other | 0.24% | +0.13% | — | |
| 44 | BPRE | Bluerock Private Real Estate | Stock-Financials | 0.24% | -0.24% | EXIT | |
| 45 | IRMD | Iradimed CORP | Stock-Other | 0.23% | -0.06% | — | |
| 46 | PAHC | Phibro Animal Health Corp-a | Stock-Other | 0.22% | -0.08% | — | |
| 47 | AGX | Argan Inc | Stock-Industrials | 0.19% | -0.04% | +14.30% | |
| 48 | BNDW | Vanguard Total World Bond Et | ETF-Other | 0.19% | -0.05% | -2.20% | |
| 49 | ADMA | Adma Biologics Inc | Stock-Healthcare | 0.18% | -0.12% | — | |
| 50 | PLOW | Douglas Dynamics Inc | Stock-Other | 0.18% | -0.07% | — |
According to official SEC Form 13F filings, Kings Path Partners LLC reported a total U.S. public equity portfolio value of $375.8M across 295 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including VTI, SCHF, GSLC) accounted for 27.8% of total reported equity market value during Q4 2025.
Top New Position Initiated
ACWI
市值: $719.5K
Top Position Liquidated / Trimmed
SMCI
前期市值: $671.2K
During Q4 2025, Kings Path Partners LLC's top holdings by market value included VTI (11.0%)、SCHF (7.8%)、GSLC (7.6%). The largest single position, VTI, represented 11.0% of total portfolio value.
In Q4 2025, Kings Path Partners LLC made 140 total portfolio adjustments, initiating 16 new buys, adding to 40 positions, trimming 51 holdings, and fully liquidating 33 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.